InvestorsHub Logo
Followers 8
Posts 665
Boards Moderated 0
Alias Born 05/09/2015

Re: TomP1 post# 20421

Saturday, 04/29/2017 2:31:10 PM

Saturday, April 29, 2017 2:31:10 PM

Post# of 34576
You bring up some good points Tom. However, what has changed since this interview ?

"But my specialty is focusing the company on getting clinical trials completed and adding value through the progression of the technology that’s in the company. And I feel that TapImmune is an ideal place to be, because the technology is so good and we really believe that we have an option here to do something exciting in the field of immuno-oncology."
-Bonfiglio

I remind you, this was 3 months ago...




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News